Tafasitamab Antibody
Tafasitamab is an Fc-engineered, humanized monoclonal antibody directed against CD19. It is a research tool for investigating B-cell malignancies, particularly diffuse large B-cell lymphoma (DLBCL), in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Apoptosis, CD19, MOR 00208, MOR00208, MOR-00208, Immunology related, Immunologyrelated, Inflammationrelated, Inflammation related, XmAb5574, Tafasitamab, Tafasitamab-cxix
Target
Immunology/Inflammation related, Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
2.39 mg/mL
Purity
95.50% (May vary between batches)
Molecular Weight
147.41 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
